Shionogi Files Japan, US NDAs for Naldemedine for Opioid-Induced Constipation

Shionogi said on March 30 that it has simultaneously filed new drug applications (NDAs) in Japan and the US for naldemedine (development code: S-297995) for the treatment of opioid-induced constipation (OIC). In Japan the agent is expected to be indicated...read more